The global burden of chronic urticaria for the patient and society*
Margarida Gonçalo(University of Coimbra), Marcus Maurer(Humboldt-Universität zu Berlin), Constance H. Katelaris(Camden and Campbelltown Hospitals), Maryam Khoshkhui(Mashhad University of Medical Sciences), Kanokvalai Kulthanan(Siriraj Hospital), Michihiro Hide(Hiroshima City Asa Citizens Hospital), César A. Galván(International Potato Center), Luís Felipe Ensina(Universidade Federal de São Paulo), Liangchun Wang(Sun Yat-sen University), Iris Medina, Clive Grattan(Guy's Hospital), Kiran Godse(D.Y. Patil University), Mona Al‐Ahmad(Ministry of Health), Moshe Ben‐Shoshan(Montreal Children's Hospital), Iman Nasr(Royal Hospital), Daria Fomina(Sechenov University), Emek Kocatürk(Bahçeşehir University), Karsten Weller(Humboldt-Universität zu Berlin), Jonathan A. Bernstein(Bernstein Clinical Research Center), Ana Giménez, Petra Staubach(Johannes Gutenberg University Mainz), Jonny Peter(University of Cape Town)
Cited by 351
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
|New England Journal of Medicine|2013|1.1k
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723